BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27639805)

  • 1. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    JAMA; 2018 Dec; 320(21):2221-2230. PubMed ID: 30512099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    Lee HJ; Kim HK; Kim BS; Han KD; Park JB; Lee H; Lee SP; Kim YJ
    PLoS One; 2021; 16(6):e0253310. PubMed ID: 34138972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
    Nagata N; Niikura R; Aoki T; Sakurai T; Moriyasu S; Shimbo T; Sekine K; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    J Gastroenterol; 2015 Nov; 50(11):1079-86. PubMed ID: 25700638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.
    Nagata N; Niikura R; Yamada A; Sakurai T; Shimbo T; Kobayashi Y; Okamoto M; Mitsuno Y; Ogura K; Hirata Y; Fujimoto K; Akiyama J; Uemura N; Koike K
    PLoS One; 2016; 11(3):e0151332. PubMed ID: 26978517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period?
    Dinçer D; Ulukal Karancı E; Akın M; Adanır H
    Turk J Gastroenterol; 2019 Jun; 30(6):505-510. PubMed ID: 31199288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
    Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
    Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
    Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
    BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.
    Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A
    Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs].
    Abrignani MG; Zullo A; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Gatta L; Imazio M; Riccio E; Rossini R; Scotto Di Uccio F; Soncini M; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    G Ital Cardiol (Rome); 2020 Mar; 21(3):228-241. PubMed ID: 32100736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Li L; Geraghty OC; Mehta Z; Rothwell PM;
    Lancet; 2017 Jul; 390(10093):490-499. PubMed ID: 28622955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal Antiinflammatory Drugs, Anticoagulation, and Upper Gastrointestinal Bleeding.
    Lee MW; Katz PO
    Clin Geriatr Med; 2021 Feb; 37(1):31-42. PubMed ID: 33213773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
    Abrignani MG; Gatta L; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Imazio M; Riccio E; Rossini R; Scotto di Uccio F; Soncini M; Zullo A; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
    Eur J Intern Med; 2021 Mar; 85():1-13. PubMed ID: 33279389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.